SCHEMBL4062113

SCHEMBL4062113

Oc1[nH]c2ccc(-c3cccs3)cc2c1-c1ccc(CN2CCOCC2)cn1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK7 P50613 2/20 0.65
DYRK3 O43781 1/20 0.65
CDK1 P06493 1/20 0.65
CDK2 P24941 1/20 0.65
GSK3B P49841 1/20 0.65
CDK5 Q00535 1/20 0.65
CAMK2G Q13555 1/20 0.65
MARK2 Q7KZI7 1/20 0.65
PIM3 Q86V86 1/20 0.65
MINK1 Q8N4C8 1/20 0.65
PRKD2 Q9BZL6 1/20 0.65
CLK4 Q9HAZ1 1/20 0.65
SGK2 Q9HBY8 1/20 0.65
STK17A Q9UEE5 1/20 0.65
CAMK2A Q9UQM7 1/20 0.65
DYRK1B Q9Y463 1/20 0.65
JAK2 O60674 2/20 0.41
CHEK1 O14757 2/20 0.40
ACHE P22303 1/20 0.40
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4057934 0.99 CDK7 (0.64) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL4059941 0.83 GSK3B (0.66) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL4066507 0.83 CDK7 (0.66) CDK7DYRK3CDK1CDK2GSK3B
Hydrochloric Acid SCHEMBL4057681 0.82 CDK7 (0.65) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL4064035 0.82 DYRK3 (0.43) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL10079716 0.81 CDK7 (0.74) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL4069900 0.81 CDK1 (0.74) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL4558231 0.81 CDK2 (0.70) CDK7DYRK3CDK1CDK2GSK3B
SCHEMBL4062133 0.81 CDK2 (0.70) CDK7DYRK3CDK1CDK2GSK3B
Hydrochloric Acid SCHEMBL4066580 0.80 CDK1 (0.72) CDK7DYRK3CDK1CDK2GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1492785-B9 2-HYDROXY-3-HETEROARYLINDOLE DERIVATIVES AS GSK3 INHIBITORS ASTRAZENECA AB (SE) 2009-10-21 EP claimed
US-20090149460-A1 New Compounds BERG STEFAN 2009-06-11 US claimed
EP-1492785-B1 2-HYDROXY-3-HETEROARYLINDOLE DERIVATIVES AS GSK3 INHIBITORS ASTRAZENECA AB (SE) 2008-12-03 EP claimed
US-7399780-B2 3-Heterocyclyl-indole inhibitors of glycogen synthase kinase-3 ASTRAZENECA AB (SE) 2008-07-15 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149460-A1 New Compounds SDHA, CYP11B2, SERPINB1 CDK7 444/4885DYRK3 4809/4885CDK1 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.